03.16.2019 Issue 163

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

 Research Consultant: Outcomes Research

York Health Economics Consortium (YHEC) is looking to recruit a Research Consultant to support a range of projects in the Outcomes Research work stream.

Senior Research Analyst (HEOR)

Scientific Writer

Medical Statistician

Health Economics & Real-World Evidence (HE-RWE) Scientist

Senior Health Economics & Real-World Evidence (HE-RWE) Scientist

Senior Health Economics/Outcomes Researcher

Senior Health Economist (HTA and Market Access)

Head of Economic Modelling

Director, Real World Value and Evidence, Oncology


Drugmakers Plan for Post-Gottlieb Landscape

Analysis: ASP Responsible for Big Savings for Medicare, Seniors

Embattled Pharma Bolsters Lobbying Efforts Amid Pushback

Centene, RxAdvance Look to Shake Up Environment Despite Skepticism

Industry Spotlight


Conferences Webinars
Causal Inference in Observational Studies and Clinical Trials Affected by Treatment Switching: A Practical Hands-on Workshop
    March 18-21, Tyrol, Austria

Statistical Methods in Economic Evaluation for Health Technology Assessment
    March 18-19, York, England

Patient Partnering in Clinical Development
    March 19-20, Berlin, Germany

Pharma Pricing and Market Access Congress 2019
    March 19-20, Amsterdam, Netherlands

On the Rise: Out-of-Pocket Healthcare Spending
    March 20

Metadata-Driven Approach for Clinical Data Lakes
    March 21

Conquering the Missing Factor in Hemophilia A: New Evidence and Management Strategies for Patients With and Without Inhibitors
    March 21

ISPOR Educational Webinar: Top 10 Trends in HEOR
    March 22


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)


Special Thanks to Our Partners:
                   Truven         
              Evidera    HealthCore    University of FL
      Xcenda    OM1    Parexel    Jefferson    Dymaxium    
      Precision Xtract    Pharmerit    eMax Health    Sciformix
       Evidence Partners     ICON